Screener
Veracyte VCYT Contract Liabilities
Discontinued — last reported Q4 '22
Contract Liabilities at other companies
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The source filing: Veracyte’s 10-K, filed March 1, 2023.
- Filed
- Mar 1, 2023
- Fiscal year
- FY2022
- Accession
- 0001384101-23-000016
| Line item | As of December 31, 2022 | As of December 31, 2021 |
|---|---|---|
| Current portion of operating lease liabilities | 4,070 | 3,630 |
| Current portion of other liabilities | 186 | 231 |
| Total current liabilities | 62,614 | 64,151 |
| Deferred revenue, net of current portion | — | 343 |
| Deferred tax liability | 4,531 | 5,592 |
| Acquisition-related contingent consideration, net of current portion | 2,498 | 5,722 |
| Operating lease liabilities, net of current portion | 10,648 | 14,096 |
| Other liabilities | 931 | 1,407 |
ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
FAQ
- What is Veracyte's contract liabilities?
- Veracyte (VCYT) reported contract liabilities of $0 in Q4 2022.
- How has Veracyte's contract liabilities changed year-over-year?
- Veracyte's contract liabilities decreased by 100.0% year-over-year, from $343K to $0.
- What is the long-term trend for Veracyte's contract liabilities?
- Over 2 years (2020 to 2022), Veracyte's contract liabilities has grown at a -100.0% compound annual growth rate (CAGR), from $829K to $0.
- What does contract liabilities mean?
- Revenue collected or billed in advance of performance — deferred revenue under ASC 606 terminology, representing future revenue obligations.
Ask your AI about Veracyte's contract liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude